Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2

Veterinary Immunology and Immunopathology

Volumn 118, Issue 1-2, 2007, Pages 121-128

  Mealey, Robert H ^a   Littke, Matt H ^a   Leib, Steven R ^a   Davis, William C ^a   McGuire, Travis C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

CTL clones; EIAV; Horse; TCR beta

Indexed keywords

MONOCLONAL ANTIBODY CD3; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL SELECTION; CLONING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DILUTION; FLOW CYTOMETRY; HORSE; LYMPHOCYTE ACTIVATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; HORSES; HUMANS; INTERLEUKIN-2; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS;

EID: 34250707860     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.04.001     Document Type: Article

References (49)

1. Allen G., Yeargan M., Costa L.R., and Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J. Virol. 69 (1995) 606-612
2. Bailey E. Identification and genetics of horse lymphocyte alloantigens. Immunogenetics 11 (1980) 499-506
3. Belshan M., Harris M.E., Shoemaker A.E., Hope T.J., and Carpenter S. Biological characterization of Rev variation in equine infectious anemia virus. J. Virol. 72 (1998) 4421-4426
4. Belshan M., Baccam P., Oaks J.L., Sponseller B.A., Murphy S.C., Cornette J., and Carpenter S. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. Virology 279 (2001) 185-200
5. Blanchard-Channell M., Moore P.F., and Stott J.L. Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5. Immunology 82 (1994) 548-554
6. Breathnach C.C., Soboll G., Suresh M., and Lunn D.P. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets. Vet. Immunol. Immunopathol. 103 (2005) 207-215
7. Brodie S.J., Lewinsohn D.A., Patterson B.K., Jiyamapa D., Krieger J., Corey L., Greenberg P.D., and Riddell S.R. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5 (1999) 34-41
8. Castillo-Olivares J., Tearle J.P., Montesso F., Westcott D., Kydd J.H., Davis-Poynter N.J., and Hannant D. Detection of equine arteritis virus (EAV)-specific cytotoxic CD8+ T lymphocyte precursors from EAV-infected ponies. J. Gen. Virol. 84 (2003) 2745-2753
9. Chung C., Mealey R.H., and McGuire T.C. CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins. Virology 327 (2004) 144-154
10. Chung C., Mealey R.H., and McGuire T.C. Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses. Virology 342 (2005) 228-239
11. Doyle M.V., Lee M.T., and Fong S. Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2. J. Biol. Response Mod. 4 (1985) 96-109
12. Hammond S.A., Cook S.J., Lichtenstein D.L., Issel C.J., and Montelaro R.C. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71 (1997) 3840-3852
13. Koenig S., Conley A.J., Brewah Y.A., Jones G.M., Leath S., Boots L.J., Davey V., Pantaleo G., Demarest J.F., Carter C., et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1 (1995) 330-336
14. Lonning S.M., Zhang W., and McGuire T.C. Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses. J. Virol. 73 (1999) 4257-4265
15. Lunn D.P., Holmes M.A., Antczak D.F., Agerwal N., Baker J., Bendali-Ahcene S., Blanchard-Channell M., Byrne K.M., Cannizzo K., Davis W., Hamilton M.J., Hannant D., Kondo T., Kydd J.H., Monier M.C., Moore P.F., O'Neil T., Schram B.R., Sheoran A., Stott J.L., Sugiura T., and Vagnoni K.E. Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995. Vet. Immunol. Immunopathol. 62 (1998) 101-143
16. McGuire T.C., Banks K.L., and Poppie M.J. Combined immunodeficiency in horses: characterization of the lymphocyte defect. Clin. Immunol. Immunopathol. 3 (1975) 555-566
17. McGuire T.C., Tumas D.B., Byrne K.M., Hines M.T., Leib S.R., Brassfield A.L., O'Rourke K.I., and Perryman L.E. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J. Virol. 68 (1994) 1459-1467
18. McGuire T.C., Zhang W., Hines M.T., Henney P.J., and Byrne K.M. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. Virology 238 (1997) 85-93
19. McGuire T.C., Leib S.R., Lonning S.M., Zhang W., Byrne K.M., and Mealey R.H. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. J. Gen. Virol. 81 (2000) 2735-2739
20. McGuire T.C., Fraser D.G., and Mealey R.H. Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus. Viral Immunol. 15 (2002) 521-531
21. McGuire T.C., Leib S.R., Mealey R.H., Fraser D.G., and Prieur D.J. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule. J. Immunol. 171 (2003) 1984-1993
22. McGuire T.C., Fraser D.G., and Mealey R.H. Cytotoxic T lymphocytes in protection against equine infectious anemia virus. Anim. Health Res. Rev. 5 (2004) 271-276
23. McGuire T.C., Poppie M.J., and Banks K.L. Combined (B- and T-lymphocyte) immunodeficiency: a fatal genetic disease in Arabian foals. J. Am. Vet. Med. Assoc. 164 (1974) 70-76
24. Mealey R.H., Fraser D.G., Oaks J.L., Cantor G.H., and McGuire T.C. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses. Clin. Immunol. 101 (2001) 237-247
25. Mealey R.H., Lee J.H., Leib S.R., Littke M.H., and McGuire T.C. A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL. J. Immunol. 177 (2006) 7377-7390
26. Mealey R.H., Zhang B., Leib S.R., Littke M.H., and McGuire T.C. Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus. Virology 313 (2003) 537-552
27. Mealey R.H., Sharif A., Ellis S.A., Littke M.H., Leib S.R., and McGuire T.C. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes. Virology 339 (2005) 110-126
28. Paillot R., Daly J.M., Juillard V., Minke J.M., Hannant D., and Kydd J.H. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine 23 (2005) 4541-4551
29. Paillot R., Ellis S.A., Daly J.M., Audonnet J.C., Minke J.M., Davis-Poynter N., Hannant D., and Kydd J.H. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 24 (2006) 1490-1500
30. Paillot R., Daly J.M., Luce R., Montesso F., Davis-Poynter N., Hannant D., and Kydd J.H. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection. Dev. Comp. Immunol. 31 (2007) 202-214
31. Patton K.M., McGuire T.C., Fraser D.G., and Hines S.A. Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect. Immun. 72 (2004) 7073-7083
32. Patton K.M., McGuire T.C., Hines M.T., Mealey R.H., and Hines S.A. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect. Immun. 73 (2005) 2083-2093
33. Perryman L.E., and Torbeck R.L. Combined immunodeficiency of Arabian horses: confirmation of autosomal recessive mode of inheritance. J. Am. Vet. Med. Assoc. 176 (1980) 1250-1251
34. Perryman L.E., O'Rourke K.I., and McGuire T.C. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 62 (1988) 3073-3076
35. Riddell S.R., Warren E.H., Gavin M.A., Akatsuka Y., Lewinsohn D., Mutimer H., Cooper L., Topp M.S., Bonini C., and Greenberg P.D. Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones. Cancer J. Sci. Am. 6 Suppl. 3 (2000) S250-S258
36. Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., and Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257 (1992) 238-241
37. Riddell S.R., Walter B.A., Gilbert M.J., and Greenberg P.D. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones. Bone Marrow Transplant. 14 Suppl. 4 (1994) S78-S84
38. Riddell S.R., and Greenberg P.D. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Meth. 128 (1990) 189-201
39. Schrenzel M.D., Watson J.L., and Ferrick D.A. Characterization of horse (Equus caballus) T-cell receptor beta chain genes. Immunogenetics 40 (1994) 135-144
40. Siliciano R.F., Keegan A.D., Dintzis R.Z., Dintzis H.M., and Shin H.S. The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones. J. Immunol. 135 (1985) 906-914
41. Soboll G., Whalley J.M., Koen M.T., Allen G.P., Fraser D.G., Macklin M.D., Swain W.F., and Lunn D.P. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes. J. Gen. Virol. 84 (2003) 2625-2634
42. Soboll G., Hussey S.B., Whalley J.M., Allen G.P., Koen M.T., Santucci N., Fraser D.G., Macklin M.D., Swain W.F., and Lunn D.P. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies. Vet. Immunol. Immunopathol. 111 (2006) 81-95
43. Terasaki P.I., Bernoco D., Park M.S., Ozturk G., and Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am. J. Clin. Pathol. 69 (1978) 103-120
44. Tschetter J.R., Davis W.C., Perryman L.E., and McGuire T.C. CD8 dimer usage on alpha beta and gama delta T lymphocytes from equine lymphoid tissues. Immunobiology 198 (1998) 424-438
45. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., and Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333 (1995) 1038-1044
46. Wiler R., Leber R., Moore B.B., VanDyk L.F., Perryman L.E., and Meek K. Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity. Proc. Natl. Acad. Sci. USA 92 (1995) 11485-11489
47. Yee C., Thompson J.A., Byrd D., Riddell S.R., Roche P., Celis E., and Greenberg P.D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. USA 99 (2002) 16168-16173
48. Zhang Y., and Frohman M.A. Using rapid amplification of cDNA ends (RACE) to obtain full-length cDNAs. Meth. Mol. Biol. 69 61/87 (1997) 61-87
49. Zhang W., Lonning S.M., and McGuire T.C. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J. Virol. 72 (1998) 9612-9620